Japan Saw its CBD Market Explode in 2023

Japan saw its CBD market explode to a value of $173.8 million in 2023, driven by recent regulatory changes that allow CBD use in diverse sectors such as healthcare and consumer goods, alongside societal shifts in attitudes towards cannabis-related products. However, while the trend is generally positive, there are still concerns over product safety and regulatory compliance in Japan.

Following recent regulatory developments, the CBD market in Japan is experiencing unprecedented growth, transitioning from a niche industry to a thriving market segment valued at $173.8 million in 2023. According to a comprehensive report by Euromonitor International, this growth reflects a paradigm shift in societal attitudes toward cannabis-related products, particularly those infused with CBD.

For more news like this, along with all the latest in legalization, research, and lifestyle, download our free cannabis news app.

Evolution of the Legal Landscape in Japan

Japan has a conservative stance on cannabis and has always deterred large corporations from investing in the sector due to legal ambiguities and negative public perception. However, recent amendments to the Japanese Cannabis Control Law marked a decisive turning point. The revised legislation, enacted in 2024, paves the way for the use of CBD in multiple sectors, including medicine, health, beauty, beverages, and edibles.

The amendments introduced crucial changes, notably the authorization of Epidiolex and the permission for hemp cultivation. This change aligns with global trends, with Euromonitor International noting that regulatory changes in other countries have prompted the Japanese Ministry of Health, Labor, and Welfare to reevaluate cannabis regulations.

Japan and CBD

The rapid expansion of the CBD market in Japan is driven by shifting consumer preferences in health and wellness products. However, Euromonitor International has noted some lingering consumer hesitation, fueled by safety concerns and incidents related to CBD-infused products.

The report clarifies: “Concerns about product safety and regulatory compliance continue, highlighted by incidents such as disorders related to CBD-infused candies containing HHCH, widely reported in the country in 2023, prompting stricter regulations.”

Evolving CBD Markets

Euromonitor International anticipates a rapid evolution of the market, driven by health-conscious consumers seeking alternatives to traditional products like cigarettes and alcohol.

The report envisions a future where CBD sales will surpass the illicit market in Japan and other cou by 2026, thanks to increased awareness and innovative product offerings. However, success depends on robust quality assurance, compliance with regulations, and comprehensive consumer education.

Despite severe penalties for the illicit use of cannabis, Japan is witnessing a significant increase in cannabis consumption, particularly among young people. The illicit market is estimated to be 2.5 times the size of the legal CBD market in 2023.

—

(Featured image by Jezael Melgoza via Unsplash)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.